Medigen Vaccine Biologics (6547) — Free Cash Flow Generation Index
Medigen Vaccine Biologics (6547) has a Free Cash Flow Generation Index of 0.97x as of December 2025. Free cash flow of NT$97.54 Million represents 1% of operating cash flow (NT$101.08 Million). Explore 6547 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medigen Vaccine Biologics Free Cash Flow Generation Index (2015–2024)
Historical FCF Generation Index trend for Medigen Vaccine Biologics across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Medigen Vaccine Biologics.
Annual Free Cash Flow Generation for Medigen Vaccine Biologics (2015–2024)
Year-by-year Free Cash Flow Generation Index for Medigen Vaccine Biologics. Check how aggressively does Medigen Vaccine Biologics reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | NT$5.77 Million | NT$40.75 Million | NT$34.98 Million | ▼ -81.5% |
| 2021 | 0.77x | NT$444.92 Million | NT$579.89 Million | NT$134.97 Million | ▲ +168.9% |
| 2015 | -1.11x | NT$-240.89 Million | NT$216.26 Million | NT$457.15 Million | — |